Zhejiang Jiuzhou Pharmaceutical Co., Ltd

Shanghai Stock Exchange 603456.SS

Zhejiang Jiuzhou Pharmaceutical Co., Ltd Goodwill for the year ending December 31, 2023: USD 15.51 M

Zhejiang Jiuzhou Pharmaceutical Co., Ltd Goodwill is USD 15.51 M for the year ending December 31, 2023, a -3.68% change year over year. Goodwill is the value attributed to intangible assets, such as brand reputation or customer relationships, acquired in a business combination.

Zhejiang Jiuzhou Pharmaceutical Co., Ltd Goodwill for the year ending December 31, 2022 was USD 16.10 M, a 45.42% change year over year.
Zhejiang Jiuzhou Pharmaceutical Co., Ltd Goodwill for the year ending December 31, 2021 was USD 11.07 M, a -3.73% change year over year.
Zhejiang Jiuzhou Pharmaceutical Co., Ltd Goodwill for the year ending December 31, 2020 was USD 11.50 M, a 6.69% change year over year.
Zhejiang Jiuzhou Pharmaceutical Co., Ltd Goodwill for the year ending December 31, 2019 was USD 10.78 M, a 0.00% change year over year.

Key data

Date	Goodwill	Total Assets	Current Liabilities	Total Non-Current Liabilities

Shanghai Stock Exchange: 603456.SS

Zhejiang Jiuzhou Pharmaceutical Co., Ltd

CEO	Mr. Yi Jiang Mei
IPO Date	Oct. 10, 2014
Location	China
Headquarters	99 Waisha Road
Employees	4,877
Sector	Health Care
Industries Pharmaceuticals Chemicals & Advanced Materials

Description

Zhejiang Jiuzhou Pharmaceutical Co., Ltd manufactures and sells active pharmaceutical ingredients (API) and intermediates in China and internationally. Its API pipeline comprise central nervous system, non-steroidal, anti-infection, hypoglycemic and antiviral, tumor treatment, anti-depressant, Parkinson, HCV drugs, diabetes, cardiovascular, and respiratory anti-infection drugs. The company also provides asymmetric catalysts and lithium battery materials. Zhejiang Jiuzhou Pharmaceutical Co., Ltd was founded in 1973 and is headquartered in Taizhou, China.

Key trends

Past 5 years